<- Go Home

Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

Market Cap

EUR 1.9B

Volume

27.4K

Cash and Equivalents

EUR 195.6M

EBITDA

EUR 309.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 773.4M

Profit Margin

65.41%

52 Week High

EUR 51.90

52 Week Low

EUR 31.70

Dividend

2.26%

Price / Book Value

3.59

Price / Earnings

14.07

Price / Tangible Book Value

-3.55

Enterprise Value

EUR 2.9B

Enterprise Value / EBITDA

9.06

Operating Income

EUR 249.0M

Return on Equity

25.57%

Return on Assets

7.11

Cash and Short Term Investments

EUR 195.6M

Debt

EUR 1.2B

Equity

EUR 533.0M

Revenue

EUR 1.2B

Unlevered FCF

EUR 183.0M

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches